GBp 4608.0
(-0.95%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 59.6 Billion | 60.07 Billion | 52.44 Billion | 50.72 Billion | 51.98 Billion | 50.98 Billion |
Cost of Revenue | 34.42 Billion | 35.9 Billion | 30.25 Billion | 28.68 Billion | 29.1 Billion | 28.76 Billion |
Gross Profit | 25.17 Billion | 24.16 Billion | 22.18 Billion | 22.04 Billion | 22.87 Billion | 22.21 Billion |
Operating Expenses | 15.13 Billion | 14.44 Billion | 12.55 Billion | 12.67 Billion | 14.17 Billion | 9.67 Billion |
Selling, General and Administrative Expenses | 8.54 Billion | 7.82 Billion | 6.87 Billion | 7.09 Billion | 13.33 Billion | 8.77 Billion |
Research and Development Expenses | 949 Million | 908 Million | 847 Million | 800 Million | 840 Million | 900 Million |
Other Expenses | -110 Million | 5.71 Billion | 4.83 Billion | 4.78 Billion | - | -1.61 Billion |
Cost and Expenses | 49.56 Billion | 50.34 Billion | 42.81 Billion | 41.35 Billion | 43.27 Billion | 38.44 Billion |
Operating Income | 9.75 Billion | 10.75 Billion | 8.7 Billion | 8.3 Billion | 8.7 Billion | 12.53 Billion |
Interest Expense | 1.07 Billion | 818 Million | 491 Million | 737 Million | 851 Million | 616 Million |
Income Tax Expense | 2.19 Billion | 2.06 Billion | 1.93 Billion | 1.92 Billion | 2.26 Billion | 2.57 Billion |
Earnings before Tax | 9.33 Billion | 10.33 Billion | 8.55 Billion | 7.99 Billion | 8.28 Billion | 12.38 Billion |
Net Income | 6.48 Billion | 7.64 Billion | 6.04 Billion | 5.58 Billion | 5.62 Billion | 9.38 Billion |
Earnings Per Share Basic | 2.56 | 2.92 | 2.33 | 2.13 | 2.15 | 3.50 |
Earnings Per Share Diluted | 2.56 | 2.92 | 2.32 | 2.12 | 2.14 | 3.48 |
Weighted Average Shares Outstanding | 2.53 Billion | 2.54 Billion | 2.59 Billion | 2.62 Billion | 2.61 Billion | 2.68 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.53 Billion | 2.62 Billion | 2.6 Billion | 2.62 Billion | 2.62 Billion | 2.69 Billion |
Gross Margin | 0.42 | 0.40 | 0.42 | 0.43 | 0.44 | 0.44 |
EBIT Margin | 0.20 | 0.22 | 0.21 | 0.21 | 0.21 | 0.29 |
Profit Margin | 0.11 | 0.13 | 0.12 | 0.11 | 0.11 | 0.18 |
EBITDA | 11.99 Billion | 13.07 Billion | 10.81 Billion | 10.71 Billion | 11.03 Billion | 15.3 Billion |
Earnings Before Tax Margin | 0.16 | 0.18 | 0.17 | 0.16 | 0.17 | 0.25 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 15.55 Billion | 15.55 Billion | 14.58 Billion | 59.6 Billion | 14.58 Billion | 15.21 Billion |
Cost of Revenue | - | - | 17.21 Billion | 34.42 Billion | 17.21 Billion | 11.44 Billion |
Gross Profit | 15.55 Billion | 15.55 Billion | -2.62 Billion | 25.17 Billion | -2.62 Billion | 3.76 Billion |
Operating Expenses | 12.57 Billion | 12.57 Billion | 4.82 Billion | 15.13 Billion | 4.82 Billion | 12.42 Billion |
Selling, General and Administrative Expenses | 17.5 Million | 17.5 Million | 7.59 Billion | - | 7.59 Billion | 25 Million |
Research and Development Expenses | - | - | 474.5 Million | - | 474.5 Million | - |
Other Expenses | - | - | -20.32 Billion | - | - | -21.43 Billion |
Cost and Expenses | 12.57 Billion | 12.57 Billion | 22.03 Billion | 49.56 Billion | 22.03 Billion | 12.42 Billion |
Operating Income | 3.06 Billion | 3.06 Billion | 2.39 Billion | 9.75 Billion | 2.39 Billion | 2.63 Billion |
Interest Expense | - | - | 449.74 Million | 1.07 Billion | - | 453.02 Million |
Income Tax Expense | 775 Million | 775 Million | 407 Million | 2.19 Billion | 407 Million | 692.5 Million |
Earnings before Tax | 2.78 Billion | 2.78 Billion | 2.03 Billion | 9.33 Billion | 2.03 Billion | 2.63 Billion |
Net Income | 1.85 Billion | 1.85 Billion | 1.46 Billion | 6.48 Billion | 1.46 Billion | 1.77 Billion |
Earnings Per Share Basic | 0.74 | 0.74 | 0.58 | - | 0.58 | 0.70 |
Earnings Per Share Diluted | 0.74 | 0.74 | 0.58 | - | 0.58 | 0.70 |
Weighted Average Shares Outstanding | 2.51 Billion | 2.51 Billion | 2.53 Billion | 2.51 Billion | 2.53 Billion | 2.53 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.51 Billion | 2.51 Billion | 2.52 Billion | 2.51 Billion | 2.52 Billion | 2.53 Billion |
Gross Margin | 1.00 | 1.00 | -0.18 | 0.42 | -0.18 | 0.25 |
EBIT Margin | 0.22 | 0.22 | 0.17 | - | 0.17 | 0.20 |
Profit Margin | 0.12 | 0.12 | 0.10 | 0.11 | 0.10 | 0.12 |
EBITDA | 3.45 Billion | 3.45 Billion | 2.51 Billion | - | 2.51 Billion | 3.01 Billion |
Earnings Before Tax Margin | 0.20 | 0.20 | 0.16 | 0.16 | 0.16 | 0.17 |
RY4C
DOM
MAXHEALTH
3985
NBCC
002870